In Brief: Meridian Medical Technologies
This article was originally published in The Gray Sheet
Executive Summary
Meridian Medical Technologies: Initiates voluntary recall of 30,000 EpiEZPen auto epinephrine-injectors for treatment of allergic reactions Sept. 22 after receiving reports that six of the devices automatically deployed, making them ineffective in an emergency. No consumers were harmed in the incidents. Less than 4% of pens currently on shelves are involved in the Class I, nationwide recall -- which is limited to lot 6SA145, distributed by Dey Laboratories after July 30, 1996, the Columbia, Maryland firm says...